CYTK
CytokineticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CYTK Profile
Cytokinetics, Incorporated
A late-stage biopharmaceutical company focused on potential treatments for debilitating diseases in which muscle performance is compromised and/or declining
350 Oyster Point Boulevard, South San Francisco, CA 94080
--
Cytokinetics, Incorporated was incorporated on August 5, 1997, under the laws of the State of Delaware. It is a clinical-stage biopharmaceutical company focused on the discovery and development of such a novel small molecule therapeutic approach to modulate muscle function as a potential treatment for critical diseases and poor medical conditions. It is currently in the development stage, focusing on scientific research, development of drug screening technology and financing.
